https://rhizomeai.com/articles/large_molecule_preclinical_testing_ind?question=what%20toxicity%20endpoints%20are%20used%20in%20preclinical%20testing%20for%20large%20molecule%20drugs%20for%20FDA%20approval%3F&showSourceNumber=81&id=5c3f3227-c6e7-458a-8701-f027886de7e4
FDA Preclinical Testing and Toxicity Endpoints for Large-Molecule Drugs, IND to BLA
Sep 27, 2026 - FDA and ICH S6(R1) nonclinical expectations for mAbs and therapeutic proteins: species selection, repeat-dose toxicity, safety pharmacology, immunogenicity,...
preclinical testinglarge moleculefdatoxicityendpoints
https://pharmasource.global/single-tag/preclinical-testing/page/3/?directory_type=general
Preclinical Testing Archives - PharmaSource
preclinical testingarchives
https://labtesting.wuxiapptec.com/2025/10/10/4-analytical-methods-commonly-used-in-oligonucleotide-preclinical-testing/
4 Analytical Methods for Oligonucleotide Preclinical Testing | WuXi AppTec
May 20, 2026 - Learn the four analytical methods that lead in oligonucleotide preclinical testing and how each supports regulatory compliance and drug development.
analytical methodspreclinical testingwuxi apptecoligonucleotide
https://virtus-rr.com/preclinical-efficacy-testing-in-respiratory-drug-development-2/
Preclinical Efficacy Testing in Respiratory Drug Development - VirTus Respiratory Research Ltd.
Apr 11, 2026 - Preclinical efficacy testing respiratory programmes are used to evaluate whether a therapeutic candidate produces a measurable biological effect in
drug developmentpreclinicalefficacytestingrespiratory